Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L, the LEAD-4 Study Investigators. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD). Diabetes Care 2009;32:1224–1230
In the print version of the article listed above, in Table 1, row 3, “C” and “A” representing “Caucasians” and “Asians,” respectively, have been transposed, thus misrepresenting the population information for this article. Row 3, column 1 should read as follows: Race (%) (C/B/A/I/O). The online version reflects these changes.